Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma

• Published in: Proceedings of the National Academy of Sciences - PNAS Vol. 104; no. 9; pp. 3466 - 3471
• Main Authors: Soroceanu, Liliana, Kharbanda, Samir, Chen, Ruihuan, Soriano, Robert H, Aldape, Ken, Misra, Anjan, Zha, Jiping, Forrest, William F, Nigro, Janice M, Modrusan, Zora, Feuerstein, Burt G, Phillips, Heidi S
• Format: Journal Article
• Language: English
• Published: United States National Academy of Sciences 27.02.2007; National Acad Sciences
• Subjects: Antibodies; Biological Sciences; Blotting, Western; Brain; carcinogenesis; Cell growth; Cell lines; Cell Proliferation; Comparative genomic hybridization; epidermal growth factor receptors; Gene Expression Profiling; gene overexpression; Genetic markers; Glioblastoma - metabolism; Glioblastoma - physiopathology; Glioma; Growth factors; Humans; Immunoprecipitation; In Situ Hybridization; Insulin; insulin-like growth factor I receptor; Insulin-Like Growth Factor II; Kinases; Messenger RNA; neoplasms; Neurons; phosphatidylinositol 3-kinase; Phosphatidylinositol 3-Kinases - metabolism; Proteins - metabolism; Receptors; Receptors, Somatomedin - metabolism; Signal amplification; Signal Transduction - physiology; stem cells; Tumors
• ISSN: 0027-8424; 1091-6490
• DOI: 10.1073/pnas.0611271104

Amplification or overexpression of growth factor receptors is a frequent occurrence in malignant gliomas. Using both expression profiling and in situ hybridization, we identified insulin-like growth factor 2 (IGF2) as a marker for a subset of glioblastomas (GBMs) that lack amplification or overexpression of EGF receptor. Among 165 primary high-grade astrocytomas, 13% of grade IV tumors and 2% of grade III tumors expressed IGF2 mRNA levels >50-fold the sample population median. IGF2-overexpressing tumors frequently displayed PTEN loss, were highly proliferative, exhibited strong staining for phospho-Akt, and belonged to a subclass of GBMs characterized by poor survival. Using a serum-free culture system, we discovered that IGF2 can substitute for EGF to support the growth of GBM-derived neurospheres. The growth-promoting effects of IGF2 were mediated by the insulin-like growth factor receptor 1 and phosphoinositide-3-kinase regulatory subunit 3 (PIK3R3), a regulatory subunit of phosphoinositide 3-kinase that shows genomic gains in some highly proliferative GBM cases. PIK3R3 knockdown inhibited IGF2-induced growth of GBM-derived neurospheres. The current results provide evidence that the IGF2-PIK3R3 signaling axis is involved in promoting the growth of a subclass of highly aggressive human GBMs that lack EGF receptor amplification. Our data underscore the importance of the phosphoinositide 3-kinase/Akt pathway for growth of high-grade gliomas and suggest that multiple molecular alterations that activate this signaling cascade may promote tumorigenesis. Further, these findings highlight the parallels between growth factors or receptors that are overexpressed in GBMs and those that support in vitro growth of tumor-derived stem-like cells.